| # | Drug | Count |
|---|---|---|
| 0 | AZACITIDINE | 190 |
| 1 | VENETOCLAX | 137 |
| 2 | BLINATUMOMAB | 122 |
| 3 | RUXOLITINIB | 87 |
| 4 | AZACITIDINE FOR | 77 |
| 5 | GILTERITINIB | 62 |
| 6 | HYDROXYUREA | 56 |
| 7 | CYTARABINE | 47 |
| 8 | DEFERASIROX | 47 |
| 9 | FLUCONAZOLE | 46 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 41 | 0.0169 |
| 1 | GILTERITINIB | 62 | 0.0152 |
| 2 | THROMBIN TOPICAL RECOMBINANT | 1 | 0.0147 |
| 3 | BLINATUMOMAB | 122 | 0.0114 |
| 4 | TELMISARTAN AND AMLODIPINE | 1 | 0.0100 |
| 5 | ECHINACEA (ANGUSTIFOLIA), TABEBUIA IMPETIGINOSA, HYDRASTIS CANADENSIS, GLANDULA SUPRARENALIS SUIS, THYMUS (SUIS), THYROIDINUM (SUIS), ARSENICUM ALBUM, BRYONIA (ALBA), COCCULUS INDICUS, COLCHICUM AUTUMNALE, LEDUM PALUSTRE, MERCURIUS CYANATUS, NATRUM SULPHURICUM, PULSATILLA (PRATENSIS), SEPIA, SILICEA, AFLATOXIN (B1) | 6 | 0.0085 |
| 6 | AZACITIDINE | 190 | 0.0063 |
| 7 | GEMTUZUMAB OZOGAMICIN | 18 | 0.0049 |
| 8 | RIVASTIGMINE TARTRATE | 2 | 0.0043 |
| 9 | QUIZARTINIB | 3 | 0.0043 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 263 |
| 1 | BCL-2 Inhibitor [EPC] | 137 |
| 2 | Kinase Inhibitor [EPC] | 98 |
| 3 | Azole Antifungal [EPC] | 87 |
| 4 | Janus Kinase Inhibitor [EPC] | 87 |
| 5 | Corticosteroid [EPC] | 72 |
| 6 | Antimetabolite [EPC] | 56 |
| 7 | Xanthine Oxidase Inhibitor [EPC] | 49 |
| 8 | Iron Chelator [EPC] | 48 |
| 9 | Anthracycline Topoisomerase Inhibitor [EPC] | 41 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthracycline Topoisomerase Inhibitor [EPC] | 41 | 0.0169 |
| 1 | CD33-directed Immunoconjugate [EPC] | 18 | 0.0049 |
| 2 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 7 | 0.0032 |
| 3 | Classical Complement Pathway Inhibitor [EPC] | 1 | 0.0031 |
| 4 | BCL-2 Inhibitor [EPC] | 137 | 0.0022 |
| 5 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 6 | Iron Chelator [EPC] | 48 | 0.0016 |
| 7 | Thrombopoietin Receptor Agonist [EPC] | 17 | 0.0011 |
| 8 | Echinocandin Antifungal [EPC] | 9 | 0.0011 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 263 | 0.0010 |